Evaxion to present new preclinical data for cytomegalovirus vaccine candidate EVX-V1 at the International Herpesvirus Workshop

Go back to Evaxion to present new preclinical data for cytomegalovirus vaccine candidate EVX-V1 at the International Herpesvirus Workshop
(NASDAQ: EVAX) Delayed: 3.27 +0.05 (1.55%)
Previous Close $3.22    52 Week High
Open $3.22    52 Week Low
Day High $3.33    P/E N/A 
Day Low $3.16    EPS
Volume 43,320